Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2025-12-28 @ 8:07 PM
Study NCT ID:
NCT00602160
Status:
UNKNOWN
Last Update Posted:
2010-11-04
First Post:
2008-01-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Therapeutic Effect of Chinese Herbal Medicine on Food Allergy
Sponsor:
Li, Xiu-Min, M.D.
Organization:
Study Overview
Official Title:
Investigation of the Efficacy of the Food Allergy Herbal Formula (FAHF-2TM) in Patients With Food Allergy - Phase II Trial
Status:
UNKNOWN
Status Verified Date:
2010-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FAHF-2
Brief Summary:
The increasing prevalence of allergic diseases in westernized countries poses a significant health problem and a tremendous burden on quality of life and healthcare expenditure. Food allergy affects as many as 6% of young children and 3% to 4% of adults. While the majority of children outgrow their allergy to milk, egg, wheat and soy, allergies to peanut, tree nuts, fish and shellfish are often life-long. Currently, there are no treatments that can cure or provide long-term remission from food allergy. Based on our preliminary studies, we hypothesize that our investigational botanical drug, FAHF-2TM, will be a safe and effective herbal therapy for food allergy. We are enrolling those age 12-45 yrs old with allergies to peanut, tree nuts, sesame, fish, and/or shellfish.
Detailed Description:
To address our hypothesis, we propose the following aims:
Aim #1: To investigate the efficacy of FAHF-2TM for food allergy (in addition to current food allergen avoidance).
Aim #2: To characterize the immunomodulatory effects of FAHF-2TM on food allergic patients
Aim #1: To investigate the efficacy of FAHF-2TM for food allergy (in addition to current food allergen avoidance).
Aim #2: To characterize the immunomodulatory effects of FAHF-2TM on food allergic patients
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| R01AT001495-01A1 | NIH | None | https://reporter.nih.gov/quic… | View |